Technical Analysis for ARAY - Accuray Incorporated
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| 1,2,3 Retracement Bearish | Bearish Swing Setup | -2.40% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -2.40% | |
| Spinning Top | Other | -2.40% | |
| Wide Bands | Range Expansion | -2.40% | |
| Oversold Stochastic | Weakness | -2.40% | |
| Wide Bands | Range Expansion | -3.55% | |
| Oversold Stochastic | Weakness | -3.55% | |
| NR7 | Range Contraction | 1.88% |
| Alert | Time |
|---|---|
| 10 DMA Support | 1 day ago |
| Down 1% | 1 day ago |
| Up 2% | 1 day ago |
| Up 1% | 1 day ago |
| 60 Minute Opening Range Breakout | 2 days ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/01/2024
Accuray Incorporated designs, develops, and sells medical radiation systems for the treatment of tumors in the body. It offers CyberKnife system, an image-guided robotic radiosurgery system used to deliver radiosurgery for the treatment of solid tumors. This system tracks, detects, and corrects for tumor and patient movement in real-time during the procedure enabling the delivery of radiation with sub-millimeter accuracy. The company also offers the TomoTherapy system, which consists of an integrated and versatile radiation therapy system used for the treatment of a range of cancer types. Accuray Incorporated markets its product through a direct sales force and distributors worldwide. The company was incorporated in 1990 and is headquartered in Sunnyvale, California.
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Cancer Solid Tumors Tumor Radiation Radiation Therapy Medical Physics Neurosurgery Radiobiology Radiosurgery Treatment Of A Range Of Cancer Cyberknife
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Cancer Solid Tumors Tumor Radiation Radiation Therapy Medical Physics Neurosurgery Radiobiology Radiosurgery Treatment Of A Range Of Cancer Cyberknife
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 4.299 |
| 52 Week Low | 1.51 |
| Average Volume | 656,549 |
| 200-Day Moving Average | 2.65 |
| 50-Day Moving Average | 2.22 |
| 20-Day Moving Average | 1.87 |
| 10-Day Moving Average | 1.67 |
| Average True Range | 0.11 |
| RSI (14) | 33.77 |
| ADX | 40.63 |
| +DI | 15.13 |
| -DI | 32.52 |
| Chandelier Exit (Long, 3 ATRs) | 1.92 |
| Chandelier Exit (Short, 3 ATRs) | 1.84 |
| Upper Bollinger Bands | 2.40 |
| Lower Bollinger Band | 1.33 |
| Percent B (%b) | 0.28 |
| BandWidth | 56.98 |
| MACD Line | -0.18 |
| MACD Signal Line | -0.18 |
| MACD Histogram | -0.0004 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.75 | ||||
| Resistance 3 (R3) | 1.76 | 1.74 | 1.73 | ||
| Resistance 2 (R2) | 1.74 | 1.71 | 1.73 | 1.72 | |
| Resistance 1 (R1) | 1.68 | 1.69 | 1.67 | 1.67 | 1.72 |
| Pivot Point | 1.66 | 1.66 | 1.65 | 1.65 | 1.66 |
| Support 1 (S1) | 1.60 | 1.63 | 1.59 | 1.59 | 1.54 |
| Support 2 (S2) | 1.58 | 1.61 | 1.57 | 1.54 | |
| Support 3 (S3) | 1.52 | 1.58 | 1.53 | ||
| Support 4 (S4) | 1.51 |
